Lilly's Q2 sales nudge up on animal health acquisition; Zoetis declares Q3 dividend; Scynexis offloads animal health CRO to Vista;

> Eli Lilly ($LLY) announced that its second-quarter revenues grew 1% year-over-year to nearly $5 billion, largely thanks to its acquisition of Novartis ($NVS) Animal Health. Release

> Zoetis ($ZTS) declared a third-quarter dividend of $0.083 a share, payable September 1. Release

> Scynexis ($SCYX) has sold its contract research and development business, which includes a screening platform used by animal health businesses, to Vista Pharma Solutions. Release

> Distributor Henry Schein ($HSIC) promoted Peter McCarthy, former head of its overseas animal health business, to president of Henry Schein Global Animal Health Group. Release

> Generic animal drugmaker Putney has hired Gary Eaton, formerly of IDEXX ($IDXX) as vice president of sales and marketing. Release

> The FDA announced that Moses Lake Professional Pharmacy in Washington is voluntarily recalling all unexpired human and veterinary drugs due to sterility concerns. Release

> The Steele Foundation awarded a 45-acre ranch in Cornville, AZ, to the University of Arizona, which plans to use the property for a proposed veterinary school. Story

> Colorado State University received $10 million from the Helen K. and Arthur E. Johnson Foundation to build an equine teaching hospital for veterinarians specializing in horse medicine. Article

> Australia's National Veterinary Care, a network of veterinary clinics, announced plans to raise $31 million in an initial public offering on the Australian Securities Exchange. Release

> VetStem Biopharma has inked a long-term partnership with VCA ($WOOF) Emergency Animal Hospital & Referral Center to provide stem cell treatments to pet owners in San Diego. Release

> The Natural Dog Company is recalling bags of its Tremenda Sticks dog chews due to potential Salmonella contamination. Release